OCTOPUS MEDICAL AS
Score · fiscal year 2025
65of 100
How to read this: the company is ahead of 79 % of small companies in the same sector in 2025. What does this mean?
Rank: 8,234 of 38,670 · Handel
Profile
Cheetah · Sprinter
High profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 75 and solidity 49 out of 100 among small companies in the same sector in 2025. Methodology
Against the sector
OCTOPUS MEDICAL AS is 15 points above the median for small companies in the same sector in 2025.
Median score 50 among 36,110 companies.
Against small companies in the same sector in 2025: operating margin 8.1% (median 2.5%) and equity ratio 43.4% (median 38.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 69 MNOK | 3 MNOK |
| Operating margin | 8.1% | 2.5% |
| Profit margin | 7.2% | 2.2% |
| Return on assets | 19.3% | 4.0% |
| Equity ratio | 43.4% | 38.3% |
| Debt-to-equity | 1.30 | 0.99 |
| Current ratio | 1.73 | 1.70 |
| Revenue growth | 15.5% | 3.5% |
| Revenue per employee | 13.78 MNOK | 1.62 MNOK |
The median and “ahead of” refer to small companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 65, OCTOPUS MEDICAL AS does better than 79% of small companies in the same sector (36,579 companies) in 2025.
Score 2023–2025
- OCTOPUS MEDICAL AS
- Median: small companies in the same sector
OCTOPUS MEDICAL AS has a score of 65 for 2025, rank 8,234 of 38,670 in the sector.
Strongest: Consistency: percentile 76 against peers. Profitability: percentile 75 against peers, operating margin 8.1% against a median of 2.5%.
No area is clearly below its peers.
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
OCTOPUS MEDICAL AS had an operating margin of 8.1% and an equity ratio of 43.4% in 2025, and ranks 8,234 of 38,670 in Handel.
From 2024 to 2025: revenue grew by 16%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 14 MNOK and 56 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 43 MNOK |
| EV/EBIT | 8.0 | 56 MNOK |
| P/B | 1.0 | 14 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 6.0% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 75 | weight 30% |
|---|---|---|
| Solidity | 49 | weight 25% |
| Liquidity | 51 | weight 15% |
| Growth | 71 | weight 15% |
| Consistency | 76 | weight 15% |
Durability: 61 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is OCTOPUS MEDICAL AS?
The operating margin was 8.1% in 2025, against a median of 2.5% among small companies in the same sector. Return on assets was 19.3%.
How solid is OCTOPUS MEDICAL AS?
The equity ratio was 43.4% in 2025 (median 38.3%). Debt-to-equity was 1.30 (median 0.99).
What is the liquidity of OCTOPUS MEDICAL AS like?
The current ratio was 1.73 in 2025 (median 1.70).
How does OCTOPUS MEDICAL AS compare in Handel?
OCTOPUS MEDICAL AS ranks 8,234 of 38,670 in Handel for 2025. Among companies of the same size (small companies) it ranks 7,738 of 36,579. Revenue changed by 15.5% from the year before.
Public contracts
- Contracts awarded since 2024
- 2
- Total awarded value since 2024
- 1.4 MNOK
| Date | Buyer | Notice | Value |
|---|---|---|---|
| 8 January 2026 | Oslo Universitetssykehus HF (hovedenhet) | 77482 UL NVR Nevrologisk avdeling Finometer - Intensjonskunngjøring | 0.1 MNOK |
| 22 September 2025 | Oslo Universitetssykehus HF (hovedenhet) | 76710 RH HLK Kardiologisk avd. ELFYS | 1.3 MNOK |
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 27 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 995725126
- Legal form
- AS
- Sector
- Handel (46.460)
- Size tier
- small
- Employees
- 5 registered 10 October 2026
- Founded
- 1 July 2010 16 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Sandakerveien 64, 0484 OSLO
- Municipality
- Oslo rank 63–221 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chair of the board
- Jan Tore Anders Andersen
- Deputy member
- Joakim Andersen Nordby
- Auditor
- REVISJONSPARTNER AS
- Accountant
- ECIT SERVICES AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 29 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 60 | 59 | 65 | |
| Rank | 11,453 | 11,814 | 8,234 | |
| Operating margin | 9.9% | 7.2% | 8.1% | |
| Return on assets | 21.0% | 17.4% | 19.3% | |
| Equity ratio | 37.5% | 46.7% | 43.4% | |
| Current ratio | 1.50 | 1.80 | 1.73 | |
| Revenue growth | – | −7.8% | 15.5% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 64.7 MNOK | 59.6 MNOK | 68.9 MNOK |
| Operating profit | 6.4 MNOK | 4.3 MNOK | 5.6 MNOK |
| Profit before tax | 4.6 MNOK | 3.6 MNOK | 4.9 MNOK |
| Net profit | 3.5 MNOK | 3.2 MNOK | 4.3 MNOK |
| Financial expenses | 1.9 MNOK | 0.9 MNOK | 1.0 MNOK |
| Total assets | 30.6 MNOK | 26.1 MNOK | 31.1 MNOK |
| Current assets | 28.2 MNOK | 24.3 MNOK | 29.8 MNOK |
| Equity | 11.5 MNOK | 12.2 MNOK | 13.5 MNOK |
| Retained earnings | 11.4 MNOK | 12.1 MNOK | 13.4 MNOK |
| Total liabilities | 19.1 MNOK | 13.9 MNOK | 17.6 MNOK |
| Current liabilities | 18.8 MNOK | 13.5 MNOK | 17.2 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 29 October 2026, accounts id 6857514.
Further
Similar companies
- FLESBERG HANDEL AS index 65, rank 8,233 · compare
- AL-MOSTAFA ASIAN FOOD AS index 65, rank 8,236 · compare
- OUTDOOR HOLDING AS index 65, rank 8,237 · compare
- MY DEKKSTRA AS index 65, rank 8,238 · compare
- BEKKE HOLDING AS index 65, rank 8,239 · compare